Alizé Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $74.6M

Alizé Pharma General Information

Description

Developer of biopharmaceutical drugs, proteins and peptides. The company's biopharmaceutical drugs, proteins and peptides identifies unacylated ghrelin, a gastrointestinal peptide hormone, as a new therapeutic class, providing therapeutic products for the treatment of diabetes, cancer and metabolic diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 15, Chemin du Saquin
  • Espace Europeen, Building G
  • 69130 Ecully
  • France
+33 04
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 15, Chemin du Saquin
  • Espace Europeen, Building G
  • 69130 Ecully
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alizé Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 20-Dec-2017 $74.6M Completed Generating Revenue
5. Later Stage VC 17-Mar-2015 Completed Generating Revenue
4. Later Stage VC 10-Sep-2014 Completed Generating Revenue
3. Later Stage VC 04-Jun-2012 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Sep-2009 $4.28M $5.68M Completed Generating Revenue
1. Early Stage VC 01-Sep-2007 $1.41M $1.41M Completed Generating Revenue
To view Alizé Pharma’s complete valuation and funding history, request access »

Alizé Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ABSA P2
ABSA P1
ABSA 2012-04
ABSA 2009-01 13,433 $1.317082 $88.24 $88.24 1x $88.24 8.61%
Ordinary 15,235 $1.317082 $60.51 $60.51 1x $60.51 9.77%
To view Alizé Pharma’s complete cap table history, request access »

Alizé Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical drugs, proteins and peptides. The company's biopharmaceutical drugs, proteins and peptide
Pharmaceuticals
Ecully, France
6 As of 2019

Lexington, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alizé Pharma Competitors (27)

One of Alizé Pharma’s 27 competitors is Dicerna Pharmaceuticals, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Gilead Formerly VC-backed Foster City, CA
Arrowhead Pharmaceuticals Corporation Pasadena, CA
You’re viewing 5 of 27 competitors. Get the full list »

Alizé Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alizé Pharma Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund Minority
CEMA Corporation Minority
Credit Agricole Investment Bank Minority
Kreaxi Venture Capital Minority
Octalfa Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Alizé Pharma FAQs

  • When was Alizé Pharma founded?

    Alizé Pharma was founded in 2007.

  • Where is Alizé Pharma headquartered?

    Alizé Pharma is headquartered in Ecully, France.

  • What is the size of Alizé Pharma?

    Alizé Pharma has 6 total employees.

  • What industry is Alizé Pharma in?

    Alizé Pharma’s primary industry is Pharmaceuticals.

  • Is Alizé Pharma a private or public company?

    Alizé Pharma is a Private company.

  • What is the current valuation of Alizé Pharma?

    The current valuation of Alizé Pharma is .

  • What is Alizé Pharma’s current revenue?

    The current revenue for Alizé Pharma is .

  • How much funding has Alizé Pharma raised over time?

    Alizé Pharma has raised $18.4M.

  • Who are Alizé Pharma’s investors?

    Bpifrance, CEMA, Credit Agricole, Kreaxi, and Octalfa are 5 of 9 investors who have invested in Alizé Pharma.

  • Who are Alizé Pharma’s competitors?

    Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, Intas Pharmaceuticals, Gilead, and Arrowhead Pharmaceuticals are some of the 27 competitors of Alizé Pharma.

  • When was Alizé Pharma acquired?

    Alizé Pharma was acquired on 20-Dec-2017.

  • Who acquired Alizé Pharma?

    Alizé Pharma was acquired by Millendo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process